Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 35580172

The antibody-drug conjugate loncastuximab tesirine for the treatment of diffuse large B-cell lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2022 Jul 28
First author
Calabretta E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Calabretta E
      type
      Author
    2. name
      Hamadani M
      type
      Author
    3. name
      Zinzani PL
      type
      Author
    4. name
      Caimi P
      type
      Author
    5. name
      Carlo-Stella C
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Calabretta E
      type
      Author
    2. name
      Hamadani M
      type
      Author
    3. name
      Zinzani PL
      type
      Author
    4. name
      Caimi P
      type
      Author
    5. name
      Carlo-Stella C
      type
      Author
    bibliography ids
    1. nci-bib-0c9d81ae7fe90f45adc1506b
    book metadata
    content sha256
    add4e4d67f3aed00dca1c72b49d6c381781e067485ec90bab5730815c2e43531
    document type
    citation
    dois
    1. 10.1182/blood.2021014663
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35580172
    immutable id
    pubmed:35580172@add4e4d67f3aed00dca1c72b49d6c381781e067485ec90bab5730815c2e43531
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    4
    name
    Blood
    nlm unique id
    7603509
    pages
    303-308
    volume
    140
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35580172
      provenance
      batch id
      9d150d55960e0c12aada
      provider
      NCBI PubMed ESummary
      record sha256
      f81cdc822c828b0dafa67e9965ca0d610acc64048bf1b2353109dbc8fcd5d49a
      response sha256
      2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
      retrieved at
      2026-09-09T23:48:09.820498+00:00
      publication date
      display
      2022 Jul 28
      precision
      day
      year
      2022
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35580172/
      title
      The antibody-drug conjugate loncastuximab tesirine for the treatment of diffuse large B-cell lymphoma.

      Preserved source evidence · Independent clinical review pending · Not medical advice